Corticosteroids as inhibitors of cysteinyl leukotriene metabolic and signaling pathways

Journal of Allergy and Clinical Immunology

Volumn 121, Issue 5, 2008, Pages 1232-1237

  Negri, Julie ^a   Early, S Brandon ^a   Steinke, John W ^a   Borish, Larry ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

corticosteroids; Cysteinyl leukotrienes; IL 4

Indexed keywords

CORTICOSTEROID; CYSTEINYL LEUKOTRIENE RECEPTOR 1; CYSTEINYL LEUKOTRIENE RECEPTOR 2; FLUTICASONE; MESSENGER RNA; PEPTIDOLEUKOTRIENE;

ADULT; ALLERGIC REACTION; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; EOSINOPHIL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; MONOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ADRENAL CORTEX HORMONES; ADULT; ANDROSTADIENES; CYSTEINE; EOSINOPHILS; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-4; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENES; MEMBRANE PROTEINS; MIDDLE AGED; MONOCYTES; RECEPTORS, LEUKOTRIENE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 42749089296     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2008.02.007     Document Type: Article

References (31)

1. Drazen J.M., Israel E., and O'Byrne P.M. Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 340 (1999) 197-206
2. Dahlen S.E. Treatment of asthma with antileukotrienes: first line or last resort therapy?. Eur J Pharmacol 533 (2006) 40-56
3. Rhen T., and Cidlowski J.A. Antiinflammatory action of glucocorticoids-new mechanisms for old drugs. N Engl J Med 353 (2005) 1711-1723
4. National Asthma Evaluation and Prevention Program. Guidelines for the diagnosis and management of asthma (1997), US Department of Health and Human Services, Bethesda (MD)
5. Sebaldt R.J., Sheller J.R., Oates J.A., Roberts II L.J., and FitzGerald G.A. Inhibition of eicosanoid biosynthesis by glucocorticoids in humans. Proc Natl Acad Sci U S A 87 (1990) 6974-6978
6. Manso G., Baker A.J., Taylor I.K., and Fuller R.W. In vivo and in vitro effects of glucocorticosteroids on arachidonic acid metabolism and monocyte function in nonasthmatic humans. Eur Respir J 5 (1992) 712-716
7. O'Shaughnessy K.M., Wellings R., Gillies B., and Fuller R.W. Differential effects of fluticasone propionate on allergen-evoked bronchoconstriction and increased urinary leukotriene E4 excretion. Am Rev Respir Dis 147 (1993) 1472-1476
8. Dworski R., Fitzgerald G.A., Oates J.A., and Sheller J.R. Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med 149 (1994) 953-959
9. Riddick C.A., Ring W.L., Baker J.R., Hodulik C.R., and Bigby T.D. Dexamethasone increases expression of 5-lipoxygenase and its activating protein in human monocytes and THP-1 cells. Eur J Biochem 246 (1997) 112-118
10. Dahlen S.E., Malmstrom K., Nizankowska E., Dahlen B., Kuna P., Kowalski M., et al. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial. Am J Respir Crit Care Med 165 (2002) 9-14
11. Vachier I., Kumlin M., Dahlen S.E., Bousquet J., Godard P., and Chanez P. High levels of urinary leukotriene E4 excretion in steroid treated patients with severe asthma. Respir Med 97 (2003) 1225-1229
12. Bel E.H., van der Veen H., Dijkman J.H., and Sterk P.J. The effect of inhaled budesonide on the maximal degree of airway narrowing to leukotriene D4 and methacholine in normal subjects in vivo. Am Rev Respir Dis 139 (1989) 427-431
13. Gyllfors P., Dahlen S.E., Kumlin M., Larsson K., and Dahlen B. Bronchial responsiveness to leukotriene D4 is resistant to inhaled fluticasone propionate. J Allergy Clin Immunol 118 (2006) 78-83
14. Laviolette M., Malmstrom K., Lu S., Chervinsky P., Pujet J.C., Peszek I., et al. Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group. Am J Respir Crit Care Med 160 (1999) 1862-1868
15. Lofdahl C.G., Reiss T.F., Leff J.A., Israel E., Noonan M.J., Finn A.F., et al. Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients. BMJ 319 (1999) 87-90
16. Virchow Jr. J.C., Prasse A., Naya I., Summerton L., and Harris A. Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids. Am J Respir Crit Care Med 162 (2000) 578-585
17. Bjermer L., Bisgaard H., Bousquet J., Fabbri L.M., Greening A.P., Haahtela T., et al. Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial. BMJ 327 (2003) 891
18. Spinozzi F., Russano A.M., Piattoni S., Agea E., Bistoni O., de Benedictis D., et al. Biological effects of montelukast, a cysteinyl-leukotriene receptor-antagonist, on T lymphocytes. Clin Exp Allergy 34 (2004) 1876-1882
19. Kanaoka Y., and Boyce J.A. Cysteinyl leukotrienes and their receptors: cellular distribution and function in immune and inflammatory responses. J Immunol 173 (2004) 1503-1510
20. Hsieh F.H., Lam B.K., Penrose J.F., Austen K.F., and Boyce J.A. T helper cell type 2 cytokines coordinately regulate immunoglobulin E-dependent cysteinyl leukotriene production by human cord blood-derived mast cells: profound induction of leukotriene C4 synthase expression by interleukin 4. J Exp Med 193 (2001) 123-133
21. Cowburn A.S., Sladek K., Soja J., Adamek L., Nizankowska E., Szczeklik A., et al. Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest 101 (1998) 834-846
22. Beller T.C., Friend D.S., Maekawa A., Lam B.K., Austen K.F., and Kanaoka Y. Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis. Proc Natl Acad Sci U S A 101 (2004) 3047-3052
23. Sousa A.R., Parikh A., Scadding G., Corrigan C.J., and Lee T.H. Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med 347 (2002) 1493-1499
24. Thivierge M., Doty M., Johnson J., Stankova J., and Rola-Pleszczynski M. IL-5 up-regulates cysteinyl leukotriene 1 receptor expression in HL-60 cells differentiated into eosinophils. J Immunol 165 (2000) 5221-5226
25. Thivierge M., Stankova J., and Rola-Pleszczynski M. IL-13 and IL-4 up-regulate cysteinyl leukotriene 1 receptor expression in human monocytes and macrophages. J Immunol 167 (2001) 2855-2860
26. Early S.B., Barekzi E., Negri J., Hise K., Borish L., and Steinke J.W. Concordant modulation of CysLT receptor expression by IL-4 and IFN-γ on peripheral immune cells. Am J Respir Cell Mol Biol 36 (2007) 715-720
27. Steinke J.W., Crouse C.D., Bradley D., Hise K., Lynch K.R., Kountakis S.E., et al. Characterization of interleukin-4 stimulated nasal polyp fibroblasts. Am J Respir Cell Mol Biol 30 (2004) 212-219
28. Heise C.E., O'Dowd B.F., Figueroa D.J., Sawyer N., Nguyen T., Im D.S., et al. Characterization of the human cysteinyl leukotriene 2 receptor. J Biol Chem 275 (2000) 30531-30536
29. Lynch K.R., O'Neill G.P., Liu Q., Im D.S., Sawyer N., Metters K.M., et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 399 (1999) 789-793
30. Figueroa J., Breyer R.M., DeFoe S.K., Kargman S., Daugherty B.L., Waldburger K., et al. Expression of the cysteinyl leukotriene 1 (CysLT1) receptor in normal human lung and peripheral blood leukocytes. Am J Respir Crit Care Med 163 (2001) 226-233
31. Figueroa D.J., Borish L., Baramki D., Philip G., Austin C.P., and Evans J.F. Expression of cysteinyl leukotriene synthetic and signaling proteins in inflammatory cells in active seasonal allergic rhinitis. Clin Exp Allergy 33 (2003) 1380-1388